Common side effects reported with retatrutide include: Nausea, vomiting, and diarrhoea (most frequent, particularly during dose escalation) Decreased appetite Constipation Injection site reactions Mild increases in heart rate Cagrilintide has demonstrated a generally well-tolerated profile, with gastrointestinal symptoms also being the most commonly reported adverse effects
Try The Veg First Trick This might be one of the simplest wellness tricks around but the science behind it is compelling
The American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk, or for those requiring additional glucose-lowering beyond metformin
Increased body fat correlates with reduced testosterone across every study examining the relationship
Additional pharmacology data is available via the National Institutes of Health and FDA drug approvals database
1 For decades, biologic medicines, despite their transformative efficacy, have been constrained by the need for injection, a barrier that limits patient acceptance and adds additional workload pressure to already strained healthcare systems
